Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Fremont California 94538

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Santa Ana California 92701

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Colorado

NEW

Apex Dermatology
Denver Colorado 80120

A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of a new study drug in Subjects with Atopic Dermatitis and Plaque Psoriasis

NEW

Colorado Skin Care
Englewood Colorado 80129

A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of a new study drug in Subjects with Atopic Dermatitis and Plaque Psoriasis

NEW

Alta Vista Dermatology
Highlands Ranch Colorado 80129

A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of a new study drug in Subjects with Atopic Dermatitis and Plaque Psoriasis

Georgia

UPDATED

Sandy Springs Georgia 30328

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Indiana

UPDATED

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

New Albany Indiana 47150

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Kentucky

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Missouri

NEW

Washington University
Saint Louis Missouri 63110

A Washington University research study seeks female participants.

Texas

UPDATED

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Virginia

UPDATED

Norfolk Virginia 23507

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Canada

UPDATED

Barrie Ontario L4M 7G1

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Markham Ontario L3P1X2

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Oakville Ontario L6J 7W5

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Peterborough Ontario K9J 5K2

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Quebec G1V 4X7

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

View More ▼

UPDATED

Richmond Hill Ontario L4B 1A5

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Surrey British Columbia V3R 6A7

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Vancouver British Columbia V5Z 4E8

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Netherlands

UPDATED

Leiden

A clinical trial to evaluate treatments using Omiganan and Placebo for patients with Atopic Dermatitis

Spain

UPDATED

Alicante 03010

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Badalona Barcelona 08916

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Barcelona 08003

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Esplugues de Llobregat Barcelona 08950

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Madrid 28006

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

View More ▼

UPDATED

Málaga 29010

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Sevilla 41009

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis

UPDATED

Valencia 46026

A clinical trial to evaluate treatments using Cyclosporine 5% solution and Placebo for patients with Atopic Dermatitis